Reproducibility of inhaled and subcutaneous insulin in Type 2 diabetic patients

被引：0

|

作者：

Perera, AD

Kapitza, C

Nosek, L

Heinemann, LW

Shapiro, DA

Fishman, RS

Heise, TC

机构：

[1] Aerogen Inc, Sunnyvale, CA USA

[2] Profil Inst Metab Res, Neuss, Germany

来源：

DIABETOLOGIA | 2001年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

815

引用

收藏

页码：A212 / A212

页数：1

相关论文

共 50 条

[11] Impact of smoking on the metabolic action of subcutaneous regular insulin in Type 2 diabetic patients
Bott, S
Shafagoi, Y
Sawicki, PT
Heise, T
DIABETOLOGIA, 2001, 44 : A25 - A25
[12] Diabetic patients' preference for inhaled insulin
Prütz, C
Toft, E
Suchdev, S
Fält, K
Walerud, B
VALUE IN HEALTH, 2006, 9 (03) : A43 - A43
[13] Inhaled Technosphere/Insulin shows a low variability in metabolic action in type 2 diabetic patients
Pfützner, A
Heise, T
Steiner, S
Heinemam, L
Rave, K
DIABETES, 2000, 49 : A121 - A121
[14] Pharmacological reproducibility of inhaled human insulin dosed pre-meal in patients with type 2 DM.
Gelfand, RA
Schwartz, SL
Horton, M
Law, CG
Pun, EF
DIABETOLOGIA, 2000, 43 : A202 - A202
[15] Related Factors of Insulin Dose Setting in Type 2 Diabetic Patients Treated with Continuous Subcutaneous Insulin Infusion
Xu, Wen
Zhang, Xiuzhen
Luo, Sihui
Zhu, Yanhua
Yan, Jinhua
Yao, Bin
Weng, Jianping
DIABETES, 2015, 64 : A258 - A258
[16] Comparison between lispro insulin and regular insulin in continuous subcutaneous insulin infusion treatment in Korea type 2 diabetic patients
Choi, SB
Kim, SD
Park, SM
DIABETES, 2000, 49 : A355 - A355
[17] Treatment satisfaction in type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen
Cappelleri, JC
Cefalu, WT
Rosenstock, J
Kourides, IA
Gerber, RA
CLINICAL THERAPEUTICS, 2002, 24 (04) : 552 - 564
[18] Good metabolic control with a continuous subcutaneous insulin infusion (CSII) in type 2 diabetic patients uncontrolled by insulin optimisation
Donnet, J. -P.
Courreges, J-P.
Clavel, S.
Gabreau, T.
Gouet, D.
Verlet, E.
Cosson, E.
Jan, P.
Cirette, B.
Leutenegger, E.
DIABETOLOGIA, 2010, 53
[19] Glycemic Exposure Is Affected Favorably by Inhaled Human Insulin (Exubera) as Compared with Subcutaneous Insulin Glargine (Lantus) in Patients with Type 2 Diabetes
Hompesch, Marcus
Kollmeier, Alexa
Rave, Klaus
Heinemann, Lutz
Mitnick, Michael
Davies, Simon
Strack, Thomas
DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (05) : 307 - 313
[20] Pharmacokinetic/Pharmacodynamic Modeling of Glucose Clamp Effects of Inhaled and Subcutaneous Insulin in Healthy Volunteers and Diabetic Patients
Landersdorfer, Cornelia B.
Jusko, William J.
DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (05) : 418 - 429

← 1 2 3 4 5 →